Yizhang Wu Selected Research

Orthopedic Procedures

2/2022

Niobium carbide (MXene) reduces UHMWPE particle-induced osteolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yizhang Wu Research Topics

Disease

3	Atrial Fibrillation 05/2023 - 01/2022
1	Cardiomyopathies (Cardiomyopathy) 11/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	Tachycardia (Tachyarrhythmias) 05/2023
1	Drug-Related Side Effects and Adverse Reactions 05/2023
1	Hemorrhage 01/2023
1	Neoplasms (Cancer) 01/2023
1	Osteolysis 02/2022
1	Transient Ischemic Attack 01/2022
1	Stroke (Strokes) 01/2022
1	Myocardial Infarction 01/2022
1	Aortic Dissection 01/2022
1	Reperfusion Injury 01/2018
1	Ischemia 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Hypoxia (Hypoxemia) 01/2018

Drug/Important Bio-Agent (IBA)

2	MXeneIBA 01/2023 - 02/2022
1	Desmoglein 2IBA 11/2023
1	Volatile Organic CompoundsIBA 10/2023
1	Dronedarone FDA Link 05/2023
1	ChitosanIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	AnticoagulantsIBA 01/2023
1	molybdenum disulfideIBA 01/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023
1	ultra-high molecular weight polyethylene (UHMWPE)IBA 02/2022
1	niobium carbideIBA 02/2022
1	CytokinesIBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	LumicanIBA 01/2022
1	empagliflozinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	gastrodinIBA 01/2018

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2023
1	Radiofrequency Ablation 05/2023
1	Percutaneous Coronary Intervention 01/2023
1	Immunotherapy 01/2023
1	Orthopedic Procedures 02/2022
1	Replacement Arthroplasty 02/2022
1	Prostheses and Implants (Prosthesis) 02/2022
1	Anesthesia 01/2022
1	Catheter Ablation 01/2022
1	Ligation 01/2018